Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Naredi

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Seminars in Oncology|June 18, 2002
Histamine as an adjunct to immunotherapyPeter Naredi
Current Opinion in Oncology|May 3, 2016
Present and future role of surgery in metastatic gastrointestinal malignanciesPeter Naredi, Roger Olofsson Bagge
Plos One|January 26, 2011
Mitochondrial function is required for secretion of DAF-28/insulin in C. elegansOla Billing, Gautam Kao, Peter Naredi
Nature Reviews. Clinical Oncology|April 15, 2015
The future of trials in surgical oncologyPeter Naredi, Michael P La Quaglia
Surgical Oncology|July 22, 2008
Why do we need a core curriculum in surgical oncology in Europe?Peter Naredi, Riccardo A Audisio, Irving Taylor
Anticancer Research|August 15, 2002
Monotherapy with histamine dihydrochloride suppresses in vivo growth of a rat sarcoma in liver and subcutisMagnus Rizell, Kristoffer Hellstrand, Per Lindnér, et al.
Family Practice|March 17, 2018
Diagnostic profile characteristics of cancer patients with frequent consultations in primary care before diagnosis: a case-control studyMarcela Ewing, Peter Naredi, Chenyang Zhang, et al.
Cancer Research|October 23, 2010
ASNA-1 activity modulates sensitivity to cisplatinOskar Hemmingsson, Gautam Kao, Maria Still, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|October 25, 2011
The effect of active warming in prehospital trauma care during road and air ambulance transportation - a clinical randomized trialPeter Lundgren, Otto Henriksson, Peter Naredi, et al.
Oncology Reports|September 3, 2009
Increased sensitivity to platinating agents and arsenite in human ovarian cancer by downregulation of ASNA1Oskar Hemmingsson, Mikael Nöjd, Gautam Kao, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Seminars in Oncology|June 18, 2002
Histamine as an adjunct to immunotherapyPeter Naredi
Current Opinion in Oncology|May 3, 2016
Present and future role of surgery in metastatic gastrointestinal malignanciesPeter Naredi, Roger Olofsson Bagge
Plos One|January 26, 2011
Mitochondrial function is required for secretion of DAF-28/insulin in C. elegansOla Billing, Gautam Kao, Peter Naredi
Nature Reviews. Clinical Oncology|April 15, 2015
The future of trials in surgical oncologyPeter Naredi, Michael P La Quaglia
Surgical Oncology|July 22, 2008
Why do we need a core curriculum in surgical oncology in Europe?Peter Naredi, Riccardo A Audisio, Irving Taylor
Anticancer Research|August 15, 2002
Monotherapy with histamine dihydrochloride suppresses in vivo growth of a rat sarcoma in liver and subcutisMagnus Rizell, Kristoffer Hellstrand, Per Lindnér, et al.
Family Practice|March 17, 2018
Diagnostic profile characteristics of cancer patients with frequent consultations in primary care before diagnosis: a case-control studyMarcela Ewing, Peter Naredi, Chenyang Zhang, et al.
Cancer Research|October 23, 2010
ASNA-1 activity modulates sensitivity to cisplatinOskar Hemmingsson, Gautam Kao, Maria Still, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|October 25, 2011
The effect of active warming in prehospital trauma care during road and air ambulance transportation - a clinical randomized trialPeter Lundgren, Otto Henriksson, Peter Naredi, et al.
Oncology Reports|September 3, 2009
Increased sensitivity to platinating agents and arsenite in human ovarian cancer by downregulation of ASNA1Oskar Hemmingsson, Mikael Nöjd, Gautam Kao, et al.
Pageof 10